Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease in which the immune system attacks the central nervous system, especially the optic nerves and spinal cord. These attacks, ...
Please provide your email address to receive an email when new articles are posted on . Horizon Therapeutics recently announced new MRI imaging data from a phase 3 clinical trial, which demonstrated ...
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune astrocytopathy primarily targeting the optic nerves and spinal cord, often driven by aquaporin-4 antibodies. Clinically, NMOSD presents ...
Background Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) are inflammatory diseases of the central nervous system with different pathogenesis, brain lesion patterns, and ...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of a new analysis of MRI data from the Phase 3 clinical trial of UPLIZNA showing a reduction in the formation of subclinical ...
New diagnostic criteria have been introduced for neuromyelitis optica (NMO), which is now to be known as neuromyelitis optica spectrum disorder (NMOSD). The new criteria were developed by an ...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the publication of a new analysis from the N-MOmentum clinical trial of UPLIZNA demonstrating the utility of a robust adjudication process that ...
Neuromyelitis optica is a rare chronic condition that causes eye pain and even vision loss. This disease happens when your own immune system attacks your nervous system. In this article, we look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results